These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9267240)

  • 21. Diagnosis of gastrointestinal graft-versus-host disease--is rectal biopsy enough?
    Nydegger A; Catto-Smith AG; Tiedemann K; Hardikar W
    Pediatr Blood Cancer; 2007 May; 48(5):561-6. PubMed ID: 16862539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histologic comparison of autologous graft-vs-host reaction and cutaneous eruption of lymphocyte recovery.
    Bauer DJ; Hood AF; Horn TD
    Arch Dermatol; 1993 Jul; 129(7):855-8. PubMed ID: 8323305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia.
    Vicent MG; Madero L; Ortega JJ; Martinez A; Gomez P; Verdeguer A; Badell I; Muñoz A; Olive T; Maldonado MS; Bureo E; Cubells J; Diaz MA;
    Bone Marrow Transplant; 2002 Jul; 30(1):9-13. PubMed ID: 12105771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A trend towards an increased incidence of chronic graft-versus-host disease following allogeneic peripheral blood progenitor cell transplantation: a case controlled study.
    Scott MA; Gandhi MK; Jestice HK; Mahendra P; Bass G; Marcus RE
    Bone Marrow Transplant; 1998 Aug; 22(3):273-6. PubMed ID: 9720741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
    Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
    Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The skin biopsy in the diagnosis of acute graft-versus-host disease in man.
    Sale GE; Lerner KG; Barker EA; Shulman HM; Thomas ED
    Am J Pathol; 1977 Dec; 89(3):621-36. PubMed ID: 23008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.
    Duarte RF; Delgado J; Shaw BE; Wrench DJ; Ethell M; Patch D; Dhillon AP; Mackinnon S; Potter MN; Quaglia AF
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):805-13. PubMed ID: 16182181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sjögren-like syndrome after bone marrow transplantation.
    Kosrirukvongs P; Chirapapaisan N; Visuthisakchai S; Issaragrisil S; Gonggetyai V
    J Med Assoc Thai; 2008 Nov; 91(11):1739-47. PubMed ID: 19127798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T; Van Lint MT; Gualandi F; Occhini D; Barbanti M; Sacchi N; Ficai G; Ghinatti C; Ferrara GB; Delfino L; Pozzi S; Morabito A; Zikos P; Vitale V; Corvo R; Frassoni F; Bacigalupo A
    Bone Marrow Transplant; 1997 Dec; 20(12):1057-62. PubMed ID: 9466278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
    Marra DE; McKee PH; Nghiem P
    J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ultrastructural similarities between the planus-like reaction of the graft versus host disease and the idiopathic lichen planus (author's transl)].
    Janin-Mercier A; Saurat JH; Bourges M; Sohier J; Didierjean L; Gluckman E
    Ann Dermatol Venereol; 1981; 108(1):49-56. PubMed ID: 7235504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histopathologic sequence of events in adult mice undergoing lethal graft-versus-host reaction developed across H-2 and/or non-H-2 histocompatibility barriers.
    Rappaport H; Khalil A; Halle-Pannenko O; Pritchard L; Dantchev D; Mathé G
    Am J Pathol; 1979 Jul; 96(1):121-42. PubMed ID: 37739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
    Tanimoto TE; Yamaguchi T; Tanaka Y; Saito A; Tajima K; Karasuno T; Kasai M; Kishi K; Mori T; Maseki N; Morishima S; Miyakoshi S; Kasai M; Ohno Y; Kim SW; Numata A; Kami M; Takaue Y; Mori S; Harada M
    Br J Haematol; 2004 May; 125(4):480-93. PubMed ID: 15142119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature.
    Esteban JM; Somlo G
    Mod Pathol; 1995 Jan; 8(1):59-64. PubMed ID: 7731943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.